LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.
LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance. It offers proven solutions to help achieve health care transformation goals, practically and reliably, in the here and now. The company's clients universally deliver more integrated, more informed, patient-centered care that is safer, more efficient, and with demonstrably better outcomes.LumiraDx makes diagnostic-led care simpler and more accessible with smarter connected diagnostics and diagnostic-led care solutions to enable better outcomes: better health, better experiences, and better value. The diagnostic system platform combines a small, portable instrument, advanced low-cost test strip, and seamless digital connectivity.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 14, 2022 | Grant | $14.20M | 1 | Bill & Melinda Gates Foundation | — | Detail |
Mar 1, 2022 | Post-IPO Debt | $56.50M | 2 | UBS O'Connor | — | Detail |
Sep 29, 2021 | IPO | $115M | — | — | — | Detail |
Dec 15, 2020 | Funding Round | $164M | — | — | — | Detail |
Oct 15, 2019 | Debt Financing | $75.15M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Bill & Melinda Gates Foundation | Yes | Grant |
UBS O'Connor | Yes | Post-IPO Debt |
Ron Zwanziger | — | Post-IPO Debt |